FOLH1 and posterior cortical atrophy: The prosperity in publications and research in the field of nuclear medicine is poised to provide a deeper understanding of the mechanisms behind PSMA-targeted therapy and imaging, thereby potentially providing widespread benefits to all PCa patients.